PCM
VNDA icon

Penserra Capital Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Penserra Capital Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33K Buy
+5,416
New +$35.4K ﹤0.01% 846
2021
Q4 		– Sell
-1,275
Closed -$21K – 1561
2021
Q3 		$21K Buy
1,275
+10
+0.8% +$175 ﹤0.01% 1241
2021
Q2 		$27K Buy
1,265
+20
+2% +$358 ﹤0.01% 1108
2021
Q1 		$18K Sell
1,245
-10
-0.8% -$162 ﹤0.01% 983
2020
Q4 		$16K Buy
1,255
+789
+169% +$9.5K ﹤0.01% 880
2020
Q3 		$4K Buy
+466
New +$4.98K ﹤0.01% 871

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Penserra Capital Management's VNDA Position: Q2 2026 in Review

Penserra Capital Management opened a new position in Vanda Pharmaceuticals (VNDA) in Q2 2026: 5,416 shares worth $33K. The stake represents ﹤0.01% of the portfolio and ranks #846 among its holdings. This is a return to the name: Penserra Capital Management previously reported a position in VNDA as recently as Q3 2021.

Penserra Capital Management first reported a position in VNDA in Q3 2020 and has held it in 6 quarters since. 172 funds tracked by Wall St. Rank hold VNDA as of Q2 2026.

  • Penserra Capital Management held 5,416 shares of Vanda Pharmaceuticals worth $33K as of Q2 2026.
  • Vanda Pharmaceuticals was a new Penserra Capital Management position in Q2 2026.
  • Vanda Pharmaceuticals made up ﹤0.01% of Penserra Capital Management's portfolio in Q2 2026, its #846 holding.
  • Penserra Capital Management first reported a position in Vanda Pharmaceuticals in Q3 2020 and has held it in 6 quarters since.
  • 172 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2026.

Based on Penserra Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.